RESUMEN
BACKGROUND: There is a growing need to improve heart preservation benefit the performance of cardiac operations, decrease morbidity, and more important, increase the donor pool. Therefore, the objective of this study was to evaluate the cardioprotective effects of Krebs-Henseleit buffer (KHB), Bretschneider-HTK (HTK), St. Thomas No. 1 (STH-1), and Celsior (CEL) solutions infused at 10°C and 20°C. METHODS: Hearts isolated from male albino Wistar rats and prepared according to Langendorff were randomly divided equally into 8 groups according to the temperature of infusion (10°C or 20°C) and cardioprotective solutions (KHB, HTK, STH-1, and CEL). After stabilization with KHB at 37°C, baseline values were collected (control) for heart rate (HR), left ventricle systolic pressure (LVSP), coronary flow (CF), maximum rate of rise of left ventricular pressure during ventricular contraction (+dP/dt) and maximum rate of fall of left ventricular pressure during left ventricular relaxation (-dP/dt). The hearts were then perfused with cardioprotective solutions for 5 minutes and kept for 2 hours in static ischemia at 20°C. Data evaluation used analysis of variance (ANOVA) in all together randomized 2-way ANOVA and Tukey's test for multiple comparisons. The level of significance chosen was P < .05. RESULTS: We observed that all 4 solutions were able to recover HR, independent of temperature. Interestingly, STH-1 solution at 20°C showed HR above baseline throughout the experiment. An evaluation of the corresponding hemodynamic values (LVSP, +dP/dt, and -dP/dt) indicated that treatment with CEL solution was superior at both temperatures compared with the other solutions, and had better performance at 20°C. When analyzing performance on CF maintenance, we observed that it was temperature dependent. However, when applying both HTK and CEL, at 10°C and 20°C respectively, indicated better protection against development of tissue edema. Multiple comparisons between treatments and hemodynamic variable outcomes showed that using CEL solution resulted in significant improvement compared with the other solutions at both temperatures. CONCLUSION: The solutions investigated were not able to fully suppress the deleterious effects of ischemia and reperfusion of the heart. However, these results allow us to conclude that temperature and the cardioprotective solution are interdependent as far as myocardial protection. Although CEL solution is the best for in myocardial protection, more studies are needed to understand the interaction between temperature and perfusion solution used. This will lead to development of better and more efficient cardioprotective methods.
Asunto(s)
Soluciones Cardiopléjicas/administración & dosificación , Isquemia Fría/efectos adversos , Paro Cardíaco Inducido/métodos , Hipotermia Inducida/efectos adversos , Daño por Reperfusión Miocárdica/prevención & control , Animales , Bicarbonatos/administración & dosificación , Cloruro de Calcio/administración & dosificación , Disacáridos/administración & dosificación , Edema Cardíaco/etiología , Edema Cardíaco/prevención & control , Electrólitos/administración & dosificación , Glucosa/administración & dosificación , Glutamatos/administración & dosificación , Glutatión/administración & dosificación , Frecuencia Cardíaca , Histidina/administración & dosificación , Magnesio/administración & dosificación , Masculino , Manitol/administración & dosificación , Daño por Reperfusión Miocárdica/etiología , Daño por Reperfusión Miocárdica/fisiopatología , Cloruro de Potasio/administración & dosificación , Procaína/administración & dosificación , Ratas , Ratas Wistar , Cloruro de Sodio/administración & dosificación , Factores de Tiempo , Trometamina/administración & dosificación , Función Ventricular Izquierda , Presión VentricularRESUMEN
O retardo mental é uma característica comum aos pacientes que buscam o Serviço de Genética Médica, apresentando heterogeneidade clínica e etiológica. Neste trabalho, estudos cromossômicos foram realizados em 30 indivíduos portadores de retardo mental e atraso psicomotor. Verificamos que 40 por cento dos indivíduos investigados apresentaram anomalias cromossômicas. Nos demais casos (60 por cento) o cariótipo foi normal. Este estudo reforça a importância da investigaçåo citogenética em indivíduos portadores de retardo mental e atraso psicomotor rastreando aberraçöes cromosssômicas numéricas ou estruturais e auxiliando no diagnóstico, prognóstico e aconselhamento gewnético das famílias
Asunto(s)
Humanos , Masculino , Femenino , Lactante , Preescolar , Niño , Adolescente , Adulto , Aberraciones Cromosómicas , Asesoramiento Genético , Discapacidad Intelectual , Trastornos PsicomotoresRESUMEN
O retardo mental e uma caracteristica comum aos pacientes que buscam o Servico de Genetica Medica, apresentando heterogeneidade clinica e etiologica. Neste trabalho, estudos cromossomicos foram realizados em 30 individuos portadores de retardo mental e atraso psicomotor: Verificamos que 40 por cento dos individuos investigados apresentaram anomalias cromossomicas. Nos demais casos (60 por cento) o cariotipo foi normal. Este estudo reforca a importancia da investigacao citogenetica em individuos portadores de retardo mental e atraso psicomotor rastreando aberracoes cromossomicas numericas ou estruturais e auxiliando no diagnostico e Aconselhamento Genetico das familias.
Asunto(s)
Discapacidad Intelectual , Aberraciones Cromosómicas , Asesoramiento Genético , Trastornos Psicomotores , Humanos , Hombres , Mujeres , Lactante , Preescolar , Niño , Adolescente , Adulto , Discapacidad Intelectual , Aberraciones Cromosómicas , Asesoramiento Genético , Trastornos Psicomotores , Humanos , Lactante , Niño , Adolescente , AdultoRESUMEN
Clinical, karyotypic, immunophenotypic, and molecular profiles of three TALL cases carrying a t(11;14) are discussed and compared with data in the literature. As previously reported, t(11;14)(p13;q11) was associated in one patient with a TALL profile of intermediate stage of maturation (CD7+, CD4+, CD8+). However, the same translocation was found to be present in another patient with a more immature, pro-TALL profile (CD7+, CD4-, CD8-). Both patients showed molecular rearrangements of the TCR beta chain gene. A third patient, with a very immature pro-TALL profile (CD34+, CD7+, CD4-, CD8-), carrying a t(11;14)(p15;q11), showed molecular rearrangements of the TCR beta and gamma chain genes, while the IgH chain genes were in germline configuration. Our data indicate that t(11;14) can also be present in TALLs of more immature stages of intrathymic development; the significant factor determining the clinical behavior of TALLs is apparently related more to cell differentiation than to the presence of this chromosome rearrangement.